Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of AZD2014
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The main purpose of the study is to establish a safe dose of the drug by providing
information on any potential side effects this drug may cause and collecting data about how a
patient's cancer responds to the drug. The study will also assess the blood levels and action
of AZD2014 in the body over a period of time and will indicate whether the drug has an effect
on the types of cancer the patients have.